Nascent Biotech (NBIO, $0.06) was a top loser this month, diving -2 to $0.06 per share. Of the 861 stocks analyzed in the Biotechnology Industry throughout this month, of them (3) exhibited an Uptrend while of them (6) were in a Downtrend. A.I.dvisor found 63 similar cases when NBIO's price dropped within one month. In out of those 63 cases, NBIO's price continued to decline in the subsequent month. Based on this historical data, A.I. thinks the odds of a Downtrend continuation for NBIO are